The clinical implications of non-alcoholic fatty liver diseases (NAFLD) derive from their potential
to progress to fibrosis and cirrhosis. Inappropriate dietary fat intake, excessive intake of …

Due to the widespread clinical use of imaging modalities such as ultrasonography, computed
tomography and magnetic resonance imaging (MRI), previously unsuspected liver masses …

Nonalcoholic fatty liver disease (NAFLD) has become one of the most common causes of liver
disease worldwide and has been recognized as a major health burden. The prevalence of …

Purpose To evaluate the relationship between nonalcoholic fatty liver disease (NAFLD) and
coronary artery disease (CAD) and to define determinants of CAD in patients with or without …

Hyperlipidemia is a known risk factor for fatty infiltration of the liver, a condition that can
progress to cirrhosis and liver failure. The objectives of this study were to document the …

AIM: To examine whether vitamin D improved viral response and predicted treatment
outcome in patients with hepatitis C virus (HCV) genotype 2-3. METHODS: Fifty patients with …

BACKGROUND: Little is known about dietary habits and their relationships with liver disease
in nonalcoholic fatty liver disease (NAFLD) patients, particularly in the absence of obesity, …

Nonalcoholic fatty liver disease (NAFLD) is a common clinical condition which is associated
with metabolic syndrome in 70% of cases. Inappropriate dietary fat intake, excessive intake …

BACKGROUND/AIMS: The independent role of soft drink consumption in non-alcoholic fatty
liver disease (NAFLD) patients remains unclear. We aimed to assess the association …

AIM: To determine whether adding vitamin D, a potent immunomodulator, improves the
hepatitis C virus (HCV) response to antiviral therapy. METHODS: Seventy-two consecutive …